Journal of Nuclear Medicine: 62 (3)

March 1, 2021; Volume 62,Issue 3

This Month in JNM

You have access
This Month in JNM
Journal of Nuclear Medicine March 1, 2021, 62 (3) 10A;

Discussions with Leaders

You have access
A Conversation Between Hong Wu and Johannes Czernin
Hong Wu and Johannes Czernin

Journal of Nuclear Medicine March 1, 2021, 62 (3) 293-295; DOI: https://doi.org/10.2967/jnumed.121.262007

The State of the Art

You have access
FAPI PET/CT: Will It End the Hegemony of ¹⁸F-FDG in Oncology?
Rodney J. Hicks, Peter J. Roselt, Kumarswamy G. Kallur, Richard W. Tothill and Linda Mileshkin

Journal of Nuclear Medicine March 1, 2021, 62 (3) 296-302; DOI: https://doi.org/10.2967/jnumed.120.256271

Hot Topics

You have access
Phantom Preparation Using a Dilution Technique
Martin A. Lodge

Journal of Nuclear Medicine March 1, 2021, 62 (3) 303; DOI: https://doi.org/10.2967/jnumed.120.257097

Continuing Education

You have access
The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism
Giuliano Mariani, Massimo Tonacchera, Mariano Grosso, Francesca Orsolini, Paolo Vitti and H. William Strauss

Journal of Nuclear Medicine March 1, 2021, 62 (3) 304-312; DOI: https://doi.org/10.2967/jnumed.120.243170

Focus on Molecular Imaging

You have access
Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
Yubin Miao and Thomas P. Quinn

Journal of Nuclear Medicine March 1, 2021, 62 (3) 313-318; DOI: https://doi.org/10.2967/jnumed.120.243840

Oncology

Clinical
- You have access
  Voxelwise and Patientwise Correlation of ¹⁸F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes
  Hiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, Talia C. Oughourlian, Issei Ueda, Hiroyuki Uetani, Catalina Raymond, Albert Lai, Timothy F. Cloughesy, Phioanh L. Nghiemphu, Linda M. Liau, Whitney B. Pope, Noriko Salamon and Benjamin M. Ellingson
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 319-325; DOI: https://doi.org/10.2967/jnumed.120.247411
- You have access
  Head-to-Head Evaluation of ¹⁸F-FES and ¹⁸F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer
  Gary A. Ulaner, Komal Jhaveri, Sarat Chandarlapaty, Vaios Hatzoglou, Christopher C. Riedl, Jason S. Lewis and Audrey Mauguen
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 326-331; DOI: https://doi.org/10.2967/jnumed.120.247882
- You have access
  Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium
  Sally F. Barrington, Ben G.J.C. Zwezerijnen, Henrica C.W. de Vet, Martijn W. Heymans, N. George Mikhaeel, Coreline N. Burggraaff, Jakoba J. Eertink, Lucy C. Pike, Otto S. Hoekstra, Josée M. Zijlstra and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 332-337; DOI: https://doi.org/10.2967/jnumed.119.238923
- You have access
  Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
  Regine Kluge, Tim Wittig, Thomas W. Georgi, Lars Kurch, Osama Sabri, W. Hamish Wallace, Tomasz Klekawka, Ana Fernández-Teijeiro, Francesco Ceppi, Jonas Karlén, Jane Pears, Michaela Cepelová, Alexander Fosså, Auke Beishuizen, Lisa Lyngsie Hjalgrim, Dieter Körholz, Christine Mauz-Körholz and Dirk Hasenclever
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 338-341; DOI: https://doi.org/10.2967/jnumed.120.247924
- You have access
  Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial
  Pieter J. Steinkamp, Bobby K. Pranger, Mei-Fang Li, Matthijs D. Linssen, Floris J. Voskuil, Lukas B. Been, Barbara L. van Leeuwen, Albert J.H. Suurmeijer, Wouter B. Nagengast, Schelto Kruijff, Robert J. van Ginkel and Gooitzen M. van Dam
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 342-347; DOI: https://doi.org/10.2967/jnumed.120.245696
- You have access
  Evaluation of ¹⁸F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion
  Michal Chodyla, Aydin Demircioglu, Benedikt M. Schaarschmidt, Stefanie Bertram, Nils Martin Bruckmann, Jennifer Haferkamp, Yan Li, Sebastian Bauer, Lars Podleska, Christoph Rischpler, Michael Forsting, Ken Herrmann, Lale Umutlu and Johannes Grueneisen
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 348-353; DOI: https://doi.org/10.2967/jnumed.120.248260
- FEATURED CLINICAL INVESTIGATION ARTICLE
  - You have access
    Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial
    Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso and Andreas Kjaer
    
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 354-359; DOI: https://doi.org/10.2967/jnumed.120.248120
- You have access
  A Microdosing Study with ^99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients
  Oana C. Kulterer, Sarah Pfaff, Wolfgang Wadsak, Nathalie Garstka, Mesut Remzi, Chrysoula Vraka, Lukas Nics, Markus Mitterhauser, Franziska Bootz, Samuele Cazzamalli, Nikolaus Krall, Dario Neri and Alexander R. Haug
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 360-365; DOI: https://doi.org/10.2967/jnumed.120.245530
Basic
- FEATURED ARTICLE OF THE MONTH
  - Open Access
    Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
    Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis and Freddy E. Escorcia
    
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 366-371; DOI: https://doi.org/10.2967/jnumed.120.244897
- You have access
  Noninvasive Evaluation of CD20 Expression Using ⁶⁴Cu-Labeled F(ab′)₂ Fragments of Obinutuzumab in Lymphoma
  Lei Kang, Cuicui Li, Zachary T. Rosenkrans, Jonathan W. Engle, Rongfu Wang, Dawei Jiang, Xiaojie Xu and Weibo Cai
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 372-378; DOI: https://doi.org/10.2967/jnumed.120.246595

Theranostics

Clinical
- You have access
  Dissimilar DNA Damage to Blood Lymphocytes After ¹⁷⁷Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy
  Philipp Ritt, Camille Jobic, Michael Beck, Christian Schmidkonz, Torsten Kuwert, Michael Uder and Michael Brand
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.120.243782
- You have access
  Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of ¹⁷⁷Lu-DOTA-EB-TATE
  Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu and Xiaoyuan Chen
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.120.248658
Basic
- You have access
  Multimodal Imaging of 2-Cycle PRRT with ¹⁷⁷Lu-DOTA-JR11 and ¹⁷⁷Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model
  Jakob Albrecht, Samantha Exner, Carsten Grötzinger, Sonal Prasad, Frank Konietschke, Nicola Beindorff, Anja A. Kühl, Vikas Prasad, Winfried Brenner and Eva J. Koziolek
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 393-398; DOI: https://doi.org/10.2967/jnumed.120.250274

Pulmonary

Clinical
- You have access
  Diagnostic Performance of Pulmonary Embolism Imaging in Patients with History of Asthma
  Matthew S. Lazarus, Yoel Kim, Bertin Mathai, Jeffrey M. Levsky, Leonard M. Freeman, Linda B. Haramati and Renee M. Moadel
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 399-404; DOI: https://doi.org/10.2967/jnumed.120.242776
- You have access
  PET Imaging Reveals Early Pulmonary Perfusion Abnormalities in HIV Infection Similar to Smoking
  Puja Kohli, Vanessa J. Kelly, Kathryn A. Hibbert, Björn Corleis, Mamary Kone, Josalyn L. Cho, Doreen DeFaria-Yeh, Douglas S. Kwon, Benjamin D. Medoff, R. Scott Harris and Tilo Winkler
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 405-411; DOI: https://doi.org/10.2967/jnumed.120.245977

Neurology

Clinical
- You have access
  Nondisplaceable Binding Is a Potential Confounding Factor in ¹¹C-PBR28 Translocator Protein PET Studies
  Gjertrud L. Laurell, Pontus Plavén-Sigray, Aurelija Jucaite, Andrea Varrone, Kelly P. Cosgrove, Claus Svarer, Gitte M. Knudsen, Karolinska Schizophrenia Project Consortium, R. Todd Ogden, Francesca Zanderigo, Simon Cervenka, Ansel T. Hillmer and Martin Schain
  
  Journal of Nuclear Medicine March 1, 2021, 62 (3) 412-417; DOI: https://doi.org/10.2967/jnumed.120.243717
- BRIEF COMMUNICATION
  - You have access
    Simplified Quantification of ¹¹C-UCB-J PET Evaluated in a Large Human Cohort
    Mika Naganawa, Jean-Dominique Gallezot, Sjoerd J. Finnema, David Matuskey, Adam Mecca, Nabeel B. Nabulsi, David Labaree, Jim Ropchan, Robert T. Malison, Deepak Cyril D’Souza, Irina Esterlis, Kamil Detyniecki, Christopher H. van Dyck, Yiyun Huang and Richard E. Carson
    
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 418-421; DOI: https://doi.org/10.2967/jnumed.120.243949

Radiopharmaceuticals

You have access
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project
Cathy S. Cutler, Elizabeth Bailey, Vijay Kumar, Sally W. Schwarz, Hee-Seung Bom, Jun Hatazawa, Diana Paez, Pilar Orellana, Lizette Louw, Fernando Mut, Hiroki Kato, Arturo Chiti, Savvas Frangos, Frederic Fahey, Gary Dillehay, Seung J. Oh, Dong S. Lee, Sze-Ting Lee, Rodolfo Nunez-Miller, Guru Bandhopadhyaya, Prasanta K. Pradhan and Andrew M. Scott

Journal of Nuclear Medicine March 1, 2021, 62 (3) 422-430; DOI: https://doi.org/10.2967/jnumed.120.247197

Errata

You have access
Erratum
Journal of Nuclear Medicine March 1, 2021, 62 (3) 404;

Letters to the Editor

You have access
Automated Segmentation of TMTV in DLBCL Patients: What About Method Measurement Uncertainty?
Eric Laffon and Roger Marthan

Journal of Nuclear Medicine March 1, 2021, 62 (3) 431; DOI: https://doi.org/10.2967/jnumed.120.256214
You have access
Reply: Automated Segmentation of TMTV in DLBCL Patients: What About Method Measurement Uncertainty?
Sally F. Barrington, Ben G.J.C. Zwezerijnen, Henrica C.W. de Vet, Martijn W. Heymans and Ronald Boellaard

Journal of Nuclear Medicine March 1, 2021, 62 (3) 432; DOI: https://doi.org/10.2967/jnumed.120.257030
You have access
Data-Driven Motion Correction in Clinical PET: A Joint Accomplishment of Creative Academia and Industry
Adam L. Kesner

Journal of Nuclear Medicine March 1, 2021, 62 (3) 433-434; DOI: https://doi.org/10.2967/jnumed.120.248187
You have access
Reply: Data-Driven Motion Correction in Clinical PET: A Joint Accomplishment of Creative Academia and Industry
Matthew D. Walker, Kevin M. Bradley and Daniel R. McGowan

Journal of Nuclear Medicine March 1, 2021, 62 (3) 435; DOI: https://doi.org/10.2967/jnumed.120.257022

SNMMI Newsline

You have access
SNMMI Newsline
Journal of Nuclear Medicine March 1, 2021, 62 (3) 11N-19N;
You have access
SNMMI Mid-Winter and ACNM Annual Meeting
Journal of Nuclear Medicine March 1, 2021, 62 (3) 11N;
You have access
SNMMI 2021 Annual Meeting
Alan Packard and Tina M. Buehner

Journal of Nuclear Medicine March 1, 2021, 62 (3) 11N;
You have access
American Cancer Society Cancer Statistics 2021 Report
Journal of Nuclear Medicine March 1, 2021, 62 (3) 12N;
You have access
Retired ABNM Diplomates
George M. Segall

Journal of Nuclear Medicine March 1, 2021, 62 (3) 13N;
You have access
In Memoriam: Anna Celler, PhD, 1951–2020
Arman Rahmim, Carlos Uribe, Alex MacKay and Glenn Wells

Journal of Nuclear Medicine March 1, 2021, 62 (3) 14N;
You have access
SNMMI Leadership Update: Advocating for Our Field
Alan B. Packard

Journal of Nuclear Medicine March 1, 2021, 62 (3) 15N;
You have access
Newsbriefs
Journal of Nuclear Medicine March 1, 2021, 62 (3) 16N-18N;
You have access
From the Literature
Journal of Nuclear Medicine March 1, 2021, 62 (3) 19N-22N;

Main menu

User menu

Search

Table of Contents

This Month in JNM

Discussions with Leaders

The State of the Art

Hot Topics

Continuing Education

Focus on Molecular Imaging

Oncology

Clinical

FEATURED CLINICAL INVESTIGATION ARTICLE

Basic

FEATURED ARTICLE OF THE MONTH

Theranostics

Clinical

Basic

Pulmonary

Clinical

Neurology

Clinical

BRIEF COMMUNICATION

Radiopharmaceuticals

Errata

Letters to the Editor

SNMMI Newsline

In this issue

Issue highlights

Jump to